CRSP Stock Forecast & Price Target
CRSP Stock
Price Forecast
The average stock forecast for
CRISPR Therapeutics AG (CRSP) in the next 12 months is 87.48 USD. This price target corresponds to an upside
of
54.86%. The range of stock forecasts for CRSP is 44.44 - 305.55 USD.
Based on the ratings of 28 analysts, the consensus recommendation for CRSP is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
44.44 |
87.48 |
81.60 |
305.55 |
| Upside |
-21.33% |
54.86% |
44.45% |
440.89% |
Recommendation Trends
The latest consensus rating for CRSP is "BUY". This is the average
recommendation of 28 analysts: 0 strong sell,
0 sell, 11 hold, 11 buy, 6 strong buy. In the previous period, 29 analysts also majorly recommmended
"HOLD" for CRSP.
CRSP Financial Stock
Forecast
Revenue This Year
from 3.51M
Revenue Next Year
from 30.23M